Efficacy and Safety of Levoketoconazole in Managing Cushing’s Syndrome: A Systematic Review
No systematic review has holistically analysed the efficacy and safety of levoketoconazole, a novel purified 2S,4R enantiomer of ketoconazole, believed to be 15- to 25-fold more potent than ketoconazole for managing Cushing’s syndrome (CS). We undertook this meta-analysis to address this knowledge g...
Saved in:
Main Authors: | Shinjan Patra, Deep Dutta, Lakshmi Nagendra, Nishant Raizada |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-08-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | https://journals.lww.com/indjem/fulltext/2024/07000/efficacy_and_safety_of_levoketoconazole_in.3.aspx |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome
by: Yasutaka Tsujimoto, et al.
Published: (2024-12-01) -
Hypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical Hypoparathyroidism
by: Pietro Locantore, et al.
Published: (2025-01-01) -
Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
by: Peter Wolf, et al.
Published: (2025-01-01) -
Multiple Osteoporotic Fractures in Cushing Syndrome: A Case Report and a Review of the Literature
by: Ariadni Spyroglou, et al.
Published: (2024-12-01) -
Finding the Culprit: Cushing Syndrome Secondary to Lung Carcinoid Tumor
by: Richard Vaca, MD, et al.
Published: (2025-01-01)